Genmab
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
GMAB | CO
Overview
Corporate Details
- ISIN(s):
- DK0010272202 (+2 more)
- LEI:
- 529900MTJPDPE4MHJ122
- Country:
- Denmark
- Address:
- Carl Jacobsens Vej 30, 2500 Valby
- Website:
- https://www.genmab.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Genmab is an international biotechnology company focused on creating and developing differentiated antibody therapeutics for the treatment of cancer and other serious diseases. The company leverages its proprietary antibody science and pioneering technology platforms to innovate next-generation treatments. Genmab's core activities involve the discovery, development, and commercialization of antibody-based products, often in collaboration with strategic partners. Its purpose is to improve the lives of patients by harnessing the power of antibodies to transform medical care.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Genmab and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-09 20:57 |
Director's Dealing
|
English | 7.1 KB | |
| 2025-09-09 20:57 |
Director's Dealing
|
English | 202.5 KB | |
| 2025-09-09 20:54 |
Share Issue/Capital Change
|
English | 8.2 KB | |
| 2025-09-09 20:54 |
Share Issue/Capital Change
|
English | 175.5 KB | |
| 2025-08-12 20:36 |
Share Issue/Capital Change
|
English | 175.2 KB | |
| 2025-08-12 20:36 |
Share Issue/Capital Change
|
English | 7.8 KB | |
| 2025-08-07 17:08 |
Earnings Release
|
English | 17.2 KB | |
| 2025-08-07 17:08 |
Earnings Release
|
English | 741.7 KB | |
| 2025-08-07 16:30 |
Regulatory News Service
|
English | 207.6 KB | |
| 2025-08-07 16:30 |
Legal Proceedings Report
|
English | 21.0 KB | |
| 2025-07-16 12:29 |
Regulatory News Service
|
English | 212.2 KB | |
| 2025-07-16 12:29 |
Earnings Release
|
English | 7.7 KB | |
| 2025-06-30 15:29 |
Transaction in Own Shares
|
English | 202.2 KB | |
| 2025-06-30 15:29 |
Transaction in Own Shares
|
English | 1.4 MB | |
| 2025-06-30 15:29 |
Transaction in Own Shares
|
English | 21.9 KB |
Automate Your Workflow. Get a real-time feed of all Genmab filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Genmab via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
